hopebuilding

Cervical cancer control 'achievable for the first time'

Page history last edited by Rosemary 7 mos ago

The developing world has the potential to control cervical cancer for the first time, say experts, thanks to new screening techniques and vaccination against the human papillomavirus (HPV). At the World Cancer Congress in Geneva, Switzerland, last week (28 August) a group of international cervical cancer researchers launched a monograph documenting current research in the field, including regional and national reports to guide policymakers.

Around 80% of the 250,000 annual cervical cancer deaths occur in developing countries. Without intervention, the researchers say, this figure could rise in coming years with growing and aging populations in many countries. A lack of resources and infrastructure mean few developing countries have conventional cytology screening programmes — where the cells of the cervix are assessed for changes caused by cancer.

But newer techniques may be more suited to developing countries. "We're moving to a point where cytological screening can be replaced both in the developed and developing world with testing for the virus that causes the disease," said Jack Cuzick, professor of epidemiology at the Wolfson Institute of Preventive Medicine, United Kingdom.

Testing for HPV DNA in cervical cells would be required less often than conventional screening, reducing the burden and cost of screening on health systems. Some tests can be performed in two hours, allowing women to be screened and treated in the same day. "This will be important in the developing world where the chances to screen will be much less common," said Cuzick.

Other simpler techniques such as painting the cervix with vinegar to find cancerous changes have also shown promise. And vaccines against HPV-16 and 18 — which cause most types of cervical cancer — have proved themselves in clinical trials, but at US$360 per person, are currently too expensive. Experts previously calculated that a course of vaccination would have to be less than US$25 to be cost effective in Latin American countries.

Jon Andrus, lead technical advisor for the immunisation unit at the Pan American Health Organization, called for the time lag between the introduction of vaccines in industrialised and developing countries to be reduced. "We all need to be working collectively to bring down the price barriers and make sure these vaccines get to the women who need them most in developing countries," he said at the press conference.

The monograph is published in the journal Vaccine.

Link to full monograph in Vaccine

This story, written by Katherine Nightingale 5 September 2008, is distributed by SciDev.Net, the Science and Development Network, a not-for-profit organization dedicated to providing reliable and authoritative information about science and technology for the developing world. Its website gives policymakers, researchers, media and civil society information and a platform to explore how science and technology can reduce poverty, improve health and raise standards of living around the world. SciDev.Net also builds developing countries' capacity for communicating science and technology through regional networks, practical guidance and specialist workshops.

Also see:

Vinegar provides simple cervical cancer screening test where Pap smears not available

For more stories about womens health, see:

A thousand people walk to save womens' lives in western Georgia

Inexpensive tracking of maternal deaths can help protect maternal health – Indian study

Hundreds run in Tanzania to increase breast cancer awareness, action

Community grants raise breast cancer awareness in Mexico

Motorbike ambulances save lives of mothers, babies, in remote areas of Africa

Fistula operation ends shame, allows women to rejoin society

Five Congo nurses create organization to aid Congo women raped by rebel fighters

Bringing health care to the patients saves womens’ lives in Mali

Trained birth attendants save mothers' lives in Ethiopia